Anesthesia News

Anesthesia

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Dahl V et al. – The findings indicate sugammadex 2.0 and 4.0 mg kg–1 can be given safely and effectively for the reversal of rocuronium–induced neuromuscular blockade in patients with cardiovascular disease undergoing noncardiac surgery.

Related Articles

Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade
Cochrane Reviews, 10/19/09    Relevance Score: 90%

Sugammadex: the first selective binding reversal agent for neuromuscular block
Journal of Clinical Anesthesia, 10/19/09    Relevance Score: 83%

Sugammadex: a guide to its use in anaesthetic practice
Drugs & Therapy Perspectives, 10/16/09    Relevance Score: 82%

Today in Regional...keeping you current

Regional & Topical Anaesthesia of Upper Airways
Indian Journal of Anaesthesia, 12/17/09

Complications associated with anesthesia administration for dental treatment in a special needs clinic
Special Care in Dentistry, 12/16/09

Influence of Sedation on Patients' Perceptions and Recovery in Patients Undergoing Minor Perianal Procedures under Spinal Saddle Block
Medical Principles and Practice, 12/15/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address